Narada’s Liquid-Cooled Energy Storage System, Center L Ultra 6.25 MWh, Ready for Global Delivery [City, State] – July 3, 2025 – Narada, a leading innovator in energy storage solutions, is pleased to announce that its cutting-edge liquid-cooled energy storage system, the Center L Ultra 6.25 MWh, is now ready for worldwide distribution. This significant milestone … Read more
It seems there’s a slight misunderstanding in the request. The provided URL leads to the “Tourism Agency Multilingual Commentary Database” (観光庁多言語解説文データベース). While it is a valuable resource, the specific entry “4th to 5th centuries” isn’t a direct “publication” date in the sense of a news article or blog post. Instead, it refers to a historical … Read more
Fujitsu Partners with ASX to Enhance ETF Trading with Advanced Technology Sydney, Australia & Tokyo, Japan – July 3, 2025 – Fujitsu announced today a significant collaboration with the Australian Securities Exchange (ASX) to develop a cutting-edge Exchange Traded Fund (ETF) trading platform. This new platform will be built upon Fujitsu’s advanced CONNEQTOR technology, originally … Read more
Narada’s Groundbreaking 6.25 MWh Center L Ultra System Poised for Global Deployment [City, State] – [Date] – Narada Power Source Co., Ltd. (Narada), a leading innovator in energy storage solutions, has announced the readiness of its highly anticipated 6.25 MWh Center L Ultra system for worldwide delivery. This significant development marks a pivotal moment in … Read more
MANAMED® LLC Earns Prestigious ISO 13485 Certification, Paving the Way for Enhanced Quality and Global Growth [City, State] – July 2, 2025 – MANAMED® LLC, a dedicated provider of innovative medical solutions, is proud to announce its achievement of ISO 13485 certification. This significant milestone underscores the company’s unwavering commitment to the highest standards of … Read more
Nektar Therapeutics Successfully Closes $115 Million Public Offering San Francisco, CA – July 2, 2025 – Nektar Therapeutics (NASDAQ: NKTR), a biopharmaceutical company dedicated to developing innovative medicines for patients suffering from cancer and autoimmune diseases, today announced the successful closing of its previously announced public offering of common stock. The offering, which included the … Read more
INOVIO Announces Proposed Public Offering to Fuel Growth and Innovation PLYMOUTH MEETING, PA – July 2, 2025 – INOVIO, a biotechnology company dedicated to developing DNA-based vaccines and therapies, announced today its intention to conduct a proposed public offering of its common stock. This strategic move aims to bolster the company’s financial position and support … Read more
TRICARE Announces Temporary Payment Suspension for Certain Services FOR IMMEDIATE RELEASE [City, State] – July 2, 2025 – TRICARE, the healthcare program for uniformed service members, retirees, and their families, has announced a temporary suspension of payments for a specific category of services. This update, released by PR Newswire Healthring, aims to ensure the continued … Read more
Sleep Apnea Market Poised for Significant Growth: DelveInsight Report Highlights 20% CAGR [City, State] – July 2, 2025 – The global sleep apnea market is projected to experience substantial acceleration, with an impressive Compound Annual Growth Rate (CAGR) of 20% anticipated during the study period of 2020-2034. This optimistic forecast comes from a comprehensive report … Read more
Ascletis® Pharmaceuticals Commences Phase IIa Study of Oral GLP-1R Agonist ASC30 in U.S. for Obesity and Overweight Patients [City, State] – July 2, 2025 – Ascletis Pharmaceuticals (HKEX: 1672), a leading biopharmaceutical company, today announced a significant milestone in its ongoing commitment to addressing metabolic diseases. The company has successfully dosed the first participants in … Read more